To assess the potential utility of C3a as a therapeutic target for ALI, we administered a C3a receptor antagonist to ALI model mice and demonstrated that this pretreatment ameliorated lung haemorrhage and oedema (Fig. 4). This evidence concerns the gene C3 and acute respiratory distress syndrome.